vs

Side-by-side financial comparison of NEKTAR THERAPEUTICS (NKTR) and UNITY BANCORP INC (UNTY). Click either name above to swap in a different company.

UNITY BANCORP INC is the larger business by last-quarter revenue ($35.3M vs $21.8M, roughly 1.6× NEKTAR THERAPEUTICS). UNITY BANCORP INC runs the higher net margin — 43.9% vs -165.4%, a 209.3% gap on every dollar of revenue. On growth, UNITY BANCORP INC posted the faster year-over-year revenue change (24.2% vs -25.3%). UNITY BANCORP INC produced more free cash flow last quarter ($44.3M vs $-65.0M). Over the past eight quarters, UNITY BANCORP INC's revenue compounded faster (17.5% CAGR vs 0.4%).

Nektar Therapeutics is an American biopharmaceutical company. The company was founded in 1990 and is based in San Francisco, California. The company develops new drug candidates by applying its proprietary PEGylation and advanced polymer conjugate technologies to modify chemical structure of substances, which improves drug characteristics like retention and solubility. It is a technology supplier to a number of pharmaceutical companies including Affymax, Amgen, Merck, Pfizer and UCB Pharma, e...

Unity Bancorp Inc is a New Jersey-headquartered financial holding company operating Unity Bank. It offers a full range of commercial and retail banking services including business loans, deposit products, mortgage services, and personal banking solutions, primarily serving small and medium-sized enterprises and individual consumers across local communities in New Jersey and eastern Pennsylvania.

NKTR vs UNTY — Head-to-Head

Bigger by revenue
UNTY
UNTY
1.6× larger
UNTY
$35.3M
$21.8M
NKTR
Growing faster (revenue YoY)
UNTY
UNTY
+49.4% gap
UNTY
24.2%
-25.3%
NKTR
Higher net margin
UNTY
UNTY
209.3% more per $
UNTY
43.9%
-165.4%
NKTR
More free cash flow
UNTY
UNTY
$109.3M more FCF
UNTY
$44.3M
$-65.0M
NKTR
Faster 2-yr revenue CAGR
UNTY
UNTY
Annualised
UNTY
17.5%
0.4%
NKTR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
NKTR
NKTR
UNTY
UNTY
Revenue
$21.8M
$35.3M
Net Profit
$-36.1M
$15.5M
Gross Margin
Operating Margin
-126.9%
55.8%
Net Margin
-165.4%
43.9%
Revenue YoY
-25.3%
24.2%
Net Profit YoY
-596.9%
34.5%
EPS (diluted)
$-4.67
$1.52

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NKTR
NKTR
UNTY
UNTY
Q4 25
$21.8M
$35.3M
Q3 25
$11.8M
$32.8M
Q2 25
$11.2M
$34.4M
Q1 25
$10.5M
$29.4M
Q4 24
$29.2M
$28.4M
Q3 24
$24.1M
$27.7M
Q2 24
$23.5M
$25.5M
Q1 24
$21.6M
$25.6M
Net Profit
NKTR
NKTR
UNTY
UNTY
Q4 25
$-36.1M
$15.5M
Q3 25
$-35.5M
$14.4M
Q2 25
$-41.6M
$16.5M
Q1 25
$-50.9M
$11.6M
Q4 24
$7.3M
$11.5M
Q3 24
$-37.1M
$10.9M
Q2 24
$-52.4M
$9.5M
Q1 24
$-36.8M
$9.6M
Gross Margin
NKTR
NKTR
UNTY
UNTY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
72.7%
Q3 24
81.6%
Q2 24
58.5%
Q1 24
60.6%
Operating Margin
NKTR
NKTR
UNTY
UNTY
Q4 25
-126.9%
55.8%
Q3 25
-268.6%
57.5%
Q2 25
-324.2%
62.6%
Q1 25
-425.8%
52.6%
Q4 24
49.2%
51.0%
Q3 24
-142.4%
52.7%
Q2 24
-211.9%
49.3%
Q1 24
-163.7%
50.0%
Net Margin
NKTR
NKTR
UNTY
UNTY
Q4 25
-165.4%
43.9%
Q3 25
-301.3%
43.8%
Q2 25
-372.2%
48.0%
Q1 25
-486.4%
39.5%
Q4 24
24.9%
40.5%
Q3 24
-153.6%
39.4%
Q2 24
-222.9%
37.1%
Q1 24
-170.1%
37.5%
EPS (diluted)
NKTR
NKTR
UNTY
UNTY
Q4 25
$-4.67
$1.52
Q3 25
$-1.87
$1.41
Q2 25
$-2.95
$1.61
Q1 25
$-0.24
$1.13
Q4 24
$-2.07
$1.13
Q3 24
$-2.66
$1.07
Q2 24
$-3.76
$0.92
Q1 24
$-0.19
$0.94

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NKTR
NKTR
UNTY
UNTY
Cash + ST InvestmentsLiquidity on hand
$15.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$89.8M
$345.6M
Total Assets
$280.4M
$3.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NKTR
NKTR
UNTY
UNTY
Q4 25
$15.1M
Q3 25
$41.0M
Q2 25
$43.0M
Q1 25
$38.9M
Q4 24
$44.3M
Q3 24
$30.1M
Q2 24
$27.9M
Q1 24
$48.6M
Total Debt
NKTR
NKTR
UNTY
UNTY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$230.8M
Q3 24
Q2 24
Q1 24
Stockholders' Equity
NKTR
NKTR
UNTY
UNTY
Q4 25
$89.8M
$345.6M
Q3 25
$85.1M
$334.0M
Q2 25
$-24.2M
$319.8M
Q1 25
$13.7M
$306.1M
Q4 24
$60.7M
$295.6M
Q3 24
$48.9M
$284.3M
Q2 24
$79.7M
$273.4M
Q1 24
$126.7M
$266.8M
Total Assets
NKTR
NKTR
UNTY
UNTY
Q4 25
$280.4M
$3.0B
Q3 25
$301.3M
$2.9B
Q2 25
$207.5M
$2.9B
Q1 25
$256.2M
$2.8B
Q4 24
$303.9M
$2.7B
Q3 24
$308.0M
$2.6B
Q2 24
$343.3M
$2.6B
Q1 24
$396.0M
$2.6B
Debt / Equity
NKTR
NKTR
UNTY
UNTY
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.78×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NKTR
NKTR
UNTY
UNTY
Operating Cash FlowLast quarter
$-65.0M
$44.9M
Free Cash FlowOCF − Capex
$-65.0M
$44.3M
FCF MarginFCF / Revenue
-298.0%
125.7%
Capex IntensityCapex / Revenue
0.1%
1.6%
Cash ConversionOCF / Net Profit
2.90×
TTM Free Cash FlowTrailing 4 quarters
$-208.7M
$81.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NKTR
NKTR
UNTY
UNTY
Q4 25
$-65.0M
$44.9M
Q3 25
$-48.8M
$45.5M
Q2 25
$-45.7M
$-25.3M
Q1 25
$-49.1M
$17.9M
Q4 24
$-46.2M
$48.0M
Q3 24
$-43.9M
$17.7M
Q2 24
$-37.7M
$-8.4M
Q1 24
$-47.9M
$15.8M
Free Cash Flow
NKTR
NKTR
UNTY
UNTY
Q4 25
$-65.0M
$44.3M
Q3 25
$-48.9M
$45.3M
Q2 25
$-45.8M
$-25.5M
Q1 25
$-49.1M
$17.6M
Q4 24
$-46.6M
$47.3M
Q3 24
$-44.6M
$17.5M
Q2 24
$-37.9M
$-8.6M
Q1 24
$-48.0M
$15.7M
FCF Margin
NKTR
NKTR
UNTY
UNTY
Q4 25
-298.0%
125.7%
Q3 25
-414.5%
138.1%
Q2 25
-409.6%
-74.2%
Q1 25
-469.0%
59.9%
Q4 24
-159.9%
166.5%
Q3 24
-184.9%
63.3%
Q2 24
-161.3%
-33.7%
Q1 24
-222.0%
61.4%
Capex Intensity
NKTR
NKTR
UNTY
UNTY
Q4 25
0.1%
1.6%
Q3 25
1.0%
0.7%
Q2 25
0.3%
0.5%
Q1 25
0.0%
1.0%
Q4 24
1.6%
2.4%
Q3 24
2.8%
0.5%
Q2 24
0.8%
0.5%
Q1 24
0.7%
0.3%
Cash Conversion
NKTR
NKTR
UNTY
UNTY
Q4 25
2.90×
Q3 25
3.16×
Q2 25
-1.54×
Q1 25
1.54×
Q4 24
-6.36×
4.17×
Q3 24
1.62×
Q2 24
-0.89×
Q1 24
1.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons